T-DM1

ado-trastuzumab emtansine · Genentech

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for T-DM1, covering 2020-03-04 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas [Phase 2]